SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Fennebresque Kim S

(Last) (First) (Middle)
1950 SPECTRUM CIRCLE

(Street)
MARIETTA GA 30067

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BlueLinx Holdings Inc. [ BXC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/07/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/07/2021 D 5,977 D $57.1652 23,873 I By grantor trust(1)
Common Stock 09/09/2021 D 3,360 D $55.4226 20,513 I By grantor trust(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) (3) (3) Common Stock 3,003 3,003 D
Restricted Stock Units (2) (4) (4) Common Stock 21,334 21,334 I By grantor trust
Restricted Stock Units (2) (5) (5) Common Stock 9,485 9,485 I By grantor trust
Restricted Stock Units (2) (6) (6) Common Stock 15,108 15,108 I By grantor trust
Restricted Stock Units (2) (7) (7) Common Stock 22,253 22,253 I By grantor trust
Restricted Stock Units (2) (8) (8) Common Stock 10,294 10,294 I By grantor trust
Restricted Stock Units (2) (9) (9) Common Stock 14,754 14,754 I By grantor trust
Restricted Stock Units (2) (10) (10) Common Stock 9,090 9,090 I By grantor trust
Explanation of Responses:
1. Shares held by a grantor trust established by the reporting person for estate planning purposes.
2. Each restricted stock unit represents a contingent right to receive one share of BlueLinx Holdings Inc. common stock.
3. The restricted stock units vest on May 20, 2022. Vested shares will be delivered to the grantor trust not later than 30 days after the vesting date.
4. The restricted stock units vested on May 21, 2021. Vested shares will be delivered to the grantor trust within 30 days after the earlier of May 21, 2030 or termination of reporting person's service on the Board of Directors.
5. The restricted stock units vested on May 17, 2020. Vested shares will be delivered to the grantor trust within 30 days after the earlier of May 17, 2029 or termination of reporting person's service on the Board of Directors.
6. The restricted stock units vested on January 11, 2019. Vested shares will be delivered to the grantor trust within 30 days after the earlier of January 11, 2028 or termination of reporting person's service on the Board of Directors.
7. The restricted stock units vested on January 11, 2018. Vested shares will be delivered to the grantor trust within 30 days after the earlier of January 11, 2027 or termination of reporting person's service on the Board of Directors.
8. The restricted stock units vested on May 20, 2017. Vested shares will be delivered to the grantor trust within 30 days after the earlier of May 20, 2026 or termination of reporting person's service on the Board of Directors.
9. The restricted stock units vested on March 31, 2017. Vested shares will be delivered to the grantor trust within 30 days after the earlier of March 31, 2026 or termination of reporting person's service on the Board of Directors.
10. The restricted stock units vested on January 13, 2016. Vested shares will be delivered to the grantor trust within 30 days after the earlier of January 13, 2025 or termination of reporting person's service on the Board of Directors.
Remarks:
/s/ Shyam K. Reddy, as attorney-in-fact for Kim S. Fennebresque 09/09/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

       Know all by these presents that the undersigned hereby constitutes and appoints each of Shyam K. Reddy, Natali Mayo, and Emilie McLaughlin, signing singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of BlueLinx Holdings Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
       The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
       This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of March 8, 2017.

                       /s/ Kim S. Fennebresque
                       Kim S. Fennebresque